The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

News of a respiratory virus spreading in China and footage of crowded hospitals has predictably led to panic among the people ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

Experts attribute this vulnerability to immature immune systems in infants and the waning of maternal antibodies during the ...

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.

The Arkansas Department of Health tracks viral respiratory diseases, including influenza, COVID-19, and respiratory syncytial ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public.

GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased ...

“In transplant recipients, particularly kidney and lung transplant patients, HMPV can cause significant morbidity.

India TV’s claims that HMPV is a mysterious virus, or speculation that a new virus may have arisen out of China, are false.